vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and First Bancorp, Inc (FNLC). Click either name above to swap in a different company.

First Bancorp, Inc is the larger business by last-quarter revenue ($25.8M vs $19.2M, roughly 1.3× Apyx Medical Corp). First Bancorp, Inc runs the higher net margin — 39.4% vs -6.8%, a 46.1% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 17.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 18.1%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.

APYX vs FNLC — Head-to-Head

Bigger by revenue
FNLC
FNLC
1.3× larger
FNLC
$25.8M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+17.2% gap
APYX
34.7%
17.5%
FNLC
Higher net margin
FNLC
FNLC
46.1% more per $
FNLC
39.4%
-6.8%
APYX
More free cash flow
FNLC
FNLC
$37.4M more FCF
FNLC
$34.6M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
18.1%
FNLC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
FNLC
FNLC
Revenue
$19.2M
$25.8M
Net Profit
$-1.3M
$10.2M
Gross Margin
62.6%
Operating Margin
0.1%
48.1%
Net Margin
-6.8%
39.4%
Revenue YoY
34.7%
17.5%
Net Profit YoY
71.9%
39.7%
EPS (diluted)
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
FNLC
FNLC
Q4 25
$19.2M
$25.8M
Q3 25
$12.9M
$24.5M
Q2 25
$11.4M
$22.5M
Q1 25
$9.4M
$21.8M
Q4 24
$14.2M
$22.0M
Q3 24
$11.5M
$20.5M
Q2 24
$12.1M
$19.2M
Q1 24
$10.2M
$18.5M
Net Profit
APYX
APYX
FNLC
FNLC
Q4 25
$-1.3M
$10.2M
Q3 25
$-2.0M
$9.1M
Q2 25
$-3.8M
$8.1M
Q1 25
$-4.2M
$7.1M
Q4 24
$-4.6M
$7.3M
Q3 24
$-4.7M
$7.6M
Q2 24
$-6.6M
$6.2M
Q1 24
$-7.6M
$6.0M
Gross Margin
APYX
APYX
FNLC
FNLC
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
FNLC
FNLC
Q4 25
0.1%
48.1%
Q3 25
-6.5%
45.2%
Q2 25
-22.6%
43.7%
Q1 25
-32.4%
39.3%
Q4 24
-21.4%
39.5%
Q3 24
-31.6%
44.6%
Q2 24
-45.7%
38.8%
Q1 24
-64.6%
39.3%
Net Margin
APYX
APYX
FNLC
FNLC
Q4 25
-6.8%
39.4%
Q3 25
-15.4%
37.0%
Q2 25
-33.2%
35.8%
Q1 25
-44.0%
32.5%
Q4 24
-32.5%
33.1%
Q3 24
-40.9%
36.9%
Q2 24
-54.0%
32.1%
Q1 24
-74.0%
32.5%
EPS (diluted)
APYX
APYX
FNLC
FNLC
Q4 25
$0.91
Q3 25
$0.81
Q2 25
$0.72
Q1 25
$0.63
Q4 24
$0.66
Q3 24
$0.68
Q2 24
$-0.19
$0.55
Q1 24
$-0.22
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
FNLC
FNLC
Cash + ST InvestmentsLiquidity on hand
$31.7M
Total DebtLower is stronger
$37.5M
$95.5M
Stockholders' EquityBook value
$14.5M
$283.1M
Total Assets
$66.8M
$3.2B
Debt / EquityLower = less leverage
2.58×
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
FNLC
FNLC
Q4 25
$31.7M
Q3 25
$25.1M
Q2 25
$29.3M
Q1 25
$31.0M
Q4 24
$31.7M
Q3 24
$28.0M
Q2 24
$32.7M
Q1 24
$37.3M
Total Debt
APYX
APYX
FNLC
FNLC
Q4 25
$37.5M
$95.5M
Q3 25
$37.5M
$95.5M
Q2 25
$37.5M
$95.0M
Q1 25
$37.5M
$70.0M
Q4 24
$37.5M
$95.0M
Q3 24
$37.5M
$95.0M
Q2 24
$70.0M
Q1 24
$70.0M
Stockholders' Equity
APYX
APYX
FNLC
FNLC
Q4 25
$14.5M
$283.1M
Q3 25
$5.8M
$274.6M
Q2 25
$7.3M
$265.5M
Q1 25
$10.5M
$259.7M
Q4 24
$14.2M
$252.5M
Q3 24
$11.0M
$256.8M
Q2 24
$14.7M
$244.7M
Q1 24
$20.3M
$242.6M
Total Assets
APYX
APYX
FNLC
FNLC
Q4 25
$66.8M
$3.2B
Q3 25
$57.4M
$3.2B
Q2 25
$58.2M
$3.2B
Q1 25
$60.2M
$3.2B
Q4 24
$64.8M
$3.2B
Q3 24
$60.7M
$3.1B
Q2 24
$65.4M
$3.1B
Q1 24
$70.7M
$3.0B
Debt / Equity
APYX
APYX
FNLC
FNLC
Q4 25
2.58×
0.34×
Q3 25
6.41×
0.35×
Q2 25
5.17×
0.36×
Q1 25
3.57×
0.27×
Q4 24
2.64×
0.38×
Q3 24
3.40×
0.37×
Q2 24
0.29×
Q1 24
0.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
FNLC
FNLC
Operating Cash FlowLast quarter
$-2.5M
$37.8M
Free Cash FlowOCF − Capex
$-2.8M
$34.6M
FCF MarginFCF / Revenue
-14.6%
133.9%
Capex IntensityCapex / Revenue
1.4%
12.5%
Cash ConversionOCF / Net Profit
3.72×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$55.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
FNLC
FNLC
Q4 25
$-2.5M
$37.8M
Q3 25
$-3.5M
$12.9M
Q2 25
$-1.2M
$7.4M
Q1 25
$-702.0K
$2.2M
Q4 24
$-2.9M
$26.0M
Q3 24
$-4.4M
$9.8M
Q2 24
$-4.3M
$6.4M
Q1 24
$-6.3M
$-1.5M
Free Cash Flow
APYX
APYX
FNLC
FNLC
Q4 25
$-2.8M
$34.6M
Q3 25
$-4.1M
$12.6M
Q2 25
$-1.5M
$7.2M
Q1 25
$-757.0K
$828.0K
Q4 24
$-3.2M
$24.6M
Q3 24
$-4.6M
$9.6M
Q2 24
$-4.6M
$6.3M
Q1 24
$-6.4M
$-1.8M
FCF Margin
APYX
APYX
FNLC
FNLC
Q4 25
-14.6%
133.9%
Q3 25
-31.5%
51.4%
Q2 25
-13.2%
32.1%
Q1 25
-8.0%
3.8%
Q4 24
-22.4%
111.7%
Q3 24
-40.0%
47.0%
Q2 24
-38.0%
32.9%
Q1 24
-62.2%
-9.8%
Capex Intensity
APYX
APYX
FNLC
FNLC
Q4 25
1.4%
12.5%
Q3 25
4.0%
1.2%
Q2 25
2.3%
0.6%
Q1 25
0.6%
6.2%
Q4 24
1.7%
6.7%
Q3 24
1.3%
0.5%
Q2 24
2.4%
0.3%
Q1 24
0.3%
1.8%
Cash Conversion
APYX
APYX
FNLC
FNLC
Q4 25
3.72×
Q3 25
1.42×
Q2 25
0.91×
Q1 25
0.31×
Q4 24
3.58×
Q3 24
1.29×
Q2 24
1.03×
Q1 24
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons